Do you want to read an article? Please log in or register.
Enhanced chemosensory sensitivity in patients with idiopathic rhinitis and its reversal by nasal capsaicin treatment
Related content
RECOMMENDED
Pulmonary Fibrosis
Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts JGJV, Dirksen CD, Kimman ML, Wijsenbeek MS
doi: 10.1186/s12931-020-01458-1.
COMMENTED
Respiratory Tract Infection
Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology
Allergy.
Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C, Bousquet J, Demoly P, Gevaert P, Hox V, Hupin C, Kalogjera L, Manole F, Mösges R, Mullol J, Muluk NB, Muraro A, Papadopoulos N, Pawankar R, Rondon C, Rundenko M, Seys SF, Toskala E, Van Gerven L, Zhang L, Zhang N, Fokkens WJ
doi: 10.1111/all.13200.
Respiratory Tract Infection
Bepotastine besilate for the treatment of perennial allergic rhinitis
Expert Opin Pharmacother.
Carrillo-Martin I, Gonzalez-Estrada A, Dimov V
doi: 10.1080/
RECOMMENDED
Pulmonary Fibrosis
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
Lancet Respir Med.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L
doi: 10.1016/S2213-2600
RECOMMENDED
Lung Cancer
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Oncol.
Baize N, Monnet I, Greillier L, Geier M, Lena H, Janicot H, Vergnenegre A, Crequit J, Lamy R, Auliac JB, Letreut J, Le Caer H, Gervais R, Dansin E, Madroszyk A, Renault PA, Le Garff G, Falchero L, Berard H, Schott R, Saulnier P, Chouaid C, Groupe Français de Pneumo-Cancérologie 01–13 investigators.
doi: 10.1016/S1470-2045(20)30461-7.
RECOMMENDED
Pulmonary Fibrosis
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med.
Vianello A, Salton F, Molena B, Turato C, Graziani ML, Braccioni F, Frassani V, Sella D, Pretto P, Paladini L, Sukthi A, Confalonieri M
doi: 10.3390/jcm9020422.
Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
Eur Respir Rev.
Ischaki E, Pantazopoulos I, Zakynthinos S
doi: 10.1183/
RECOMMENDED
Pulmonary Fibrosis
The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L
doi: 10.1016/j.jcf.2020.07.022.
Respiratory Tract Infection
The Impact of Allergic Rhinitis on Symptom Improvement in Pediatric Patients After Adenotonsillectomy
Clin Exp Otorhinolaryngol.
Lee DJ, Chung YJ, Yang YJ, Mo JH
doi: 10.21053/ceo.2017.00500.